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Most previous studies of University Spinouts (USOs) have focused on what determines their 
formation from the perspectives of the entrepreneurs or their parent universities, with few 
studies investigating how these entrepreneurial businesses actually grow and the role of the 
evolving business models in the process. This paper examines the evolution of business models 
in university spinouts during different phases of their development. Based on empirical 
evidence gathered from three comprehensive case studies, this paper aims to answer how USOs 
business model evolves, and the ways in which interactions between and within the core 
components of their business model would result in financial sustainability and operational 
scalability. This work extends existing research on the development of USOs, and highlights 
three themes for future research. 
 






1. Introduction  
There has been growing interest among policymakers and academics to generate greater 
economic (and social) values from publicly funded research projects. University Spinouts 
(USOs) are regarded as a crucial vehicle to commercialise intellectual properties, particularly 
those that cannot be easily patented or transacted through a license agreement (Sørheim et al. 
2011). USOs are a subset of new business start-ups, and their formation is dependent on (a) 
formal transfer of Intellectual Property (IP) rights from the university, and (b) an equity 
investment made by the university (Wright et al. 2006). There has been a sharp rise in USO 
formation throughout the world in recent years (Djokovic, Souitaris 2008). Though most 
university spinouts do not generate significant wealth (Lockett, Wright 2005), which can be 
attributed to the complex process of venture formation and uncertainty regarding how best to 
develop a business concept (Rasmussen 2011).    
The context of university spinout is distinct and significant since they characteristically involve 
in the development of business opportunities based on novel and disruptive innovation or tacit 
knowledge emerged from academic environment (Markman et al. 2008). Although many USOs 
are characterised as new high-tech start-ups, they face two fundamentally different obstacles 
compared to other typical start-ups. They face specific challenges to become established in a 
competitive environment, because most universities lack commercial resources and academic 
entrepreneurs often lacked commercial experiences (Vohora et al. 2004). Furthermore, growth 
of an USO is often held back by conflicts in the objectives of key stakeholders, such as the 
senior management of the university, the academic entrepreneurs and the venture’s 
management team (Miller et al. 2014).  
Most previous studies of university spinouts have focused on what determines their formation 
and emergence, with few studies investigating whether and how they actually grow and reach 
a suitable level of sustainability. These studies can be classified into three broad categories. 
The first category focused on the resource configuration of USOs to examine the links between 
the firm performance and its tangible and intangible assets (Barney, et al. 2001, Heirman, 
Clarysse 2004). The second category is based on the institutional arrangement of USOs to 
address how institutional context shape the development of such firms (Clarysse et al. 2005, 
Lockett et al. 2005).  The third, and a rapidly emerging category focused on the Business 
Models (BMs) of USOs, which examined the activities carried out by USOs, their product or 
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service market choice and the way they transform knowledge into value streams (Chiesa, 
Piccaluga 2002, Druilhe, Garnsey 2004, Mustar et al. 2006).  
 
Studies that looked into USOs based on their business models have focused either on the 
activities performed by the spinout or on the characteristics of the market, with some important 
aspects under-researched. First, in many cases, the development process was described as a 
single snapshot, and the transformation of the business models through different phases of the 
USOs growth and development was largely ignored (Rasmussen 2011). Vohora et al.  (2004) 
indicated that as the USOs evolve, their internal and external resources, their relationship with 
the parent firm and connections with the outside world will change in intensity and nature. 
Therefore, as one of the key aims of this research, we argue that a more dynamic approach 
towards the business model concept in the context of USO is required to understand how the 
core components of their BM evolve over the development phases.  
 
Secondly, although previous studies have examined the notion of formation and growth in the 
university spinout context (e.g. Vohora et al. 2004 and Mustar et al. 2006), there is a gap in the 
literature relating to how USOs would actually reach a financially sustainable and operationally 
scalable phase. Despite being likely environment for high-tech firm creation, ironically 
universities and academic entrepreneurs are ill-suited to sustain the growth pace of new 
ventures due to potential conflicts of interest with their tradition role of teaching and research. 
As a result, it is taking much longer, if ever, for spinouts to return the initial investment and to 
expand their operations in global scales (PraxisUnico 2012). We attempt to address this issue 
by investigating the ongoing dynamics results from the interaction between and within the core 
component of USOs’ business model in their development path.    
 
Therefore, this paper aims to address the questions of “how USOs business model evolves, and 
the way in which interactions between and within the core components of their business model 
would ultimately result in sustainability and scalability”. To address these questions, we draw 
upon two theoretical frameworks; first we adopt the Development Process Framework initially 
proposed by Vohora et al. (2004) to explore and explain the formation and growth of USOs 
throughout five non-linear phases. Secondly, we build on Lecocq et al.’s (2010) RCOV 
framework in order to ground the concept of business model in a parsimonious and dynamic 
perspective. Based on empirical evidence gathered from three comprehensive case studies, we 
discuss how the core components of the USO’s business model (proposed by RCOV 
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framework) have evolved and the extent to which the interaction among the components have 
resulted in sustainability and scalability throughout the development stages (proposed by the 
Development Process Framework). 
 
We make several contributions to understanding the business model evolution, sustainability 
and scalability in the context of university spinouts. In particular, this research is a finer grained 
analysis of Vohora et al.’s model in which the business model is broken down into three core 
components as per the RCOV model. This original approach provide a novel context in which 
to begin to fill the research gap regarding the ways that core components of university spinouts’ 
BM evolve throughout the development stages. The business model perspective offers the 
possibility to have a holistic view of the USO’s value creation logic. Moreover, using business 
model perspective to address the topic of organisation change and evolution is consistent with 
the concerns of both practitioners and academics (Moyon, Lecocq 2013) 
 
This paper is structured as follows. Section 2 explains the development of university spinouts 
and the critical issues to be addressed in order to pass through different phases. Section 3 
outlines the scope of business models for USOs and their evolution. Subsequently the study 
context and the research design will be presented in Section 4, followed by a description of the 
case studies. Section 6 presents the discussion on the empirical findings and highlights the key 
lessons learnt. The final section considers the contributions to the theory and practice, and 
discusses the directions for the future studies.      
2. The Development Process of University Spinouts 
Smith et al. (1985) argued organisation development follows some unique stages, in which as 
those stages progress, so do the organisational characteristics such as structure and strategies. 
One advantage of using the stage-based perspective is that it helps academics and practitioners 
understand the process of growth, explain how it happens and highlight the effects it has on the 
organisation (Kazanjian 1988). Drawing on the USO Development Process Framework 
initially developed by Vohora et al. (2004), we divide the evolution of USOs into six non-linear 
phases (Figure 1).  Each spinout should pass through the previous step to progress to the next 
one but each phase includes an iterative, non-linear process of development in which there may 
be a need to revisit some of the earlier decisions and activities. Moreover, a USO would 
typically experience several “critical junctures” to pass from one phase to another. 
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<< Figure 1 >> 
 
Many university spinouts emerge from scientific research that has carried out in research 
centres and academic school over several years (Vohora et al. 2004, Shane 2004). This phase 
is referred to as the research phase, also known as the “idea phase” (Clarysse, Moray 2004), 
where the academic entrepreneur started to realise that the knowledge created in the university 
has potential opportunity for commercialisation. Subsequently, the transition between the 
recognised opportunity and forming the USO takes place, when the entrepreneur scientists 
focus on identifying appropriate internal and external resources. Some previous research 
explored the process leading from opportunity recognition to firm creation (Delmar, Davidsson 
2000), and empirical evidence suggested that that during this phase the entrepreneurs begin to 
examine the potential markets, the applications to be developed to satisfy those markets and 
the best way to approach the customers (Vohora et al. 2004).    
Once the opportunity is identified and framed, academic engagement and commitment need to 
be considered before progressing to the pre-organisation phase. Bjørnåli and Gulbrandsen 
(2010) pointed out that during this transition academic entrepreneurs evolve into the 
management team and the board. The commitment of the board is vital for a potential USO to 
be taken forward from a recognised idea that has been created academically, to creating of a 
firm that is operational in the business environment.  
In the pre-organisation phase, the USO’s board and management team start to develop and 
implement strategic business plans with the key objective of acquiring required resources 
(Vohora et al. 2004). During this phase, the management team make decisions regarding who 
and where to can obtain external resources and knowledge as well as internal resources from 
the parent organisation i.e. the university. Few studies systematically examined the link 
between the capability of individual academic entrepreneurs and the level of internal and 
external funding they can acquire. However, recent empirical evidence illustrate that there is 
significant positive relationship between the university’s business development capabilities 
and the ability to attract external equity finance (Lockett et al. 2005, Hewitt-Dundas 2012).  
The transition from the pre-organisational phase to a fully operational phase depends critically 
on the entrepreneur’s ability to gain financial credibility (Vohora et al. 2004). Credibility has 
been regarded as one of the key challenges for new start-ups in general (Birley, Norburn 1985) 
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and university spinouts in specific (Wright et al. 2006).  This issue is more significant for USOs 
for two reasons; first, the key assets of USOs are typically intangible in the form of knowledge 
and a set of patents, and second, the founding team often have limited knowledge and 
experience in product development, sustainable supply chain, distribution channel and target 
market. As a result, the resource providers (such as venture capital companies) often regard 
USOs as high-risk firms for the investment. Many venture capital firms also find that the 
decision making processes within a university environment are often not aligned with the time-
scale they operate (Wright, et al. 2012).  
After the USOs had gained sufficient financial resources (Vohora et al. 2004), the focus shifts 
to offering something of value to potential customers and generate returns. During this phase, 
the academic entrepreneurs and their partners often need to reorganise their resources, which 
further increase the level of their financial credibility (Wright et al. 2012). Ambos and 
Birkinshaw (2010) discussed the necessity of re-configuration of the resources within the 
development life-cycle as it brings significant competitive advantage to the firms. The phase 
by phase transitions need to be effectively executed to position the USO in a sustainable 
structure.  This will enable the USO to become a standalone entity, or one that can be acquired 
by an incumbent. Vohora et al. (2004) discussed that the sustainability phase requires USO to 
develop entrepreneurial competencies, which enable the firm to reconfigure deficiency from 
early phases into resource strengths and social outcome. In the previous phase, the academic 
entrepreneurs had to find the route and obtain resources to commence business operations. In 
this phase, in order to overcome the juncture of sustainability, the founding team should gain 
the ability to reconfigure existing resources and capabilities through information and 
knowledge they obtained through previous phases.       
Nevertheless, reaching this point (i.e. Sustainability phase) does not mean the USO has the 
capability of scaling up its operations. Scalability can be defined as the extent to which the firm 
has the potential to serve larger numbers of customers and decrease costs through the use of 
technologies, equipment, and centralised facilities (Zhao et al. 2013). Scalability enables the 
USO to deliver the service offering at a lower cost and to exploit the potential to serve a larger 
number of customers than its competitors. This phase is conceived as a recurrence loop. This 
means that after the USO becomes financially sustainable, it may start to scale-up its operations 
in order to produce more products/services and serve more customers. After each point of 
scalability, the firm requires to be sustainable at that point before any further growth.  In order 
to reach to this point, the business model should be in a re-orientation mode to ensure first, the 
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integration among the resources is in place so the USO has the capability to develop products 
to meet the commercial needs (Sirmon et al. 2011) and second, it is flexible in terms of three 
main factors: the market, the customers and the competition.  
3. Business Model Evolution in University Spinouts   
The aim of this paper is to understand the evolution of university spinout’s business model over 
their development stages en route for sustainability and scalability. The concept of business 
model has been largely developing since the introduction of the Internet, when the firms in e-
Commerce industry had to explain to their potential investors how they could capture value 
and generate profit from technology (Chesbrough, Rosenbloom 2002). While the fundamentals 
of the so-called “digital economy” remained hazy in the late 90’s, entrepreneurs used business 
model to express the essence of emerging start-ups and to prove their viability (Magretta 2002).  
Following Demil and Lecocq (2010), we perceive of the business model as the way an 
organisation operates to ensure its sustainability and scalability.  
Considering several different approaches towards the business model concept, from those who 
look at the concept from an entrepreneurial perspective (e.g.  Kim, Mauborgne 2000, and 
Johnson et al. 2008) to those who view it as a tool to represent the way companies capture and 
create value (e.g. Mahadevan 2000, and Casadesus-Masanell, Ricart 2010a), the academic 
literature on the concept appears to be a rich and heterogeneous corpus. Though, business 
model is generally employed to represent the state of a firm or an industry at a specific moment. 
Hence, research tends to neglect a dynamic outlook in understanding the way in which the 
business model(s) of a firm evolve through time, in which “the relationship between business 
model and time is little discussed (…) it is a snapshot and description at a specific moment in 
time” (Osterwalder et al 2005: p.15). Previous studies with more “static perspective” focuses 
on identifying and describing the main components of a business model, including resources 
and capabilities, value network, collaboration, and customers. (e.g. Osterwalder 2004, Johnson 
et al. 2008). In contrast, those with “transformational perspective” uses business model as a 
tool to address the transformation and evolution of organisation or the business model itself 
over time, focusing on the interactions among the core components for the specific organisation 
under study (e.g. Casadesus-Masanell, Ricart 2010b, Moyon, Lecocq 2013). 
The main weakness of the static perspective is that it assumes that the same elements are 
equally central or core in all types of firms and organisations (Siggelkow 2002). The formation 
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and growth of university spinouts is rarely just based on the formal configuration of key 
components. During the early phases of a USO’s development, the entrepreneurs are often not 
clear about their final product/service, which limits their ability to articulate coherent value 
propositions or identifying customer segments. Therefore, in order to reconcile these two 
approaches, we use the RCOV framework to facilitate the analysis of the business model 
evolution at various stages of USO’s development. The RCOV framework was initially 
inspired by the Penrosian view (Penrose 1960) of the firm, which constitute a parsimonious 
and dynamic approach of the business model (Demil, Lecocq 2010). Based on this view, the 
business model of a given firm is an outline of the ongoing interactions between the core 
components of a business.  
The basic assumption of the framework is that the growth of a firm results from the interaction 
between its Resources and Competencies (RC) to propose novel value propositions in market, 
the Organisation (O) of the firm within the its value network, and the Value proposition (V) 
through the supply of products and/or services. Note that the three core components each 
encompass several different aspects – such as various kinds of resources and different types of 
partners within the value network. Consequently, the structure and volume of the firm’s 
revenues and costs is an outcome of the choices made relatively to the three components.     
In the context of university spinout, the resources usually come from the parent university or 
the initial research grant from either public research funding bodies or private funders. The 
competences refer to the abilities and knowledge of the academic founder(s) developed to 
leverage or improve the products/services offered. The second component, the organisational 
structure, encompasses the USO’s board formation, and the activities and interactions it 
establishes with other firms to combine and exploits its IP. This includes the relationship and 
interaction between the firm and the University Technology Transfer Office (TTO). In most 
cases, the initial board is formed by three main representatives; the academic entrepreneur, a 
representative from the University and one from the initial funding body. The third key 
component of a business model is the value propositions in the form of products or services 
that a USO delivers to its potential customers. In general, the value proposition of spinouts is 
defined around the technological innovation or the IP developed prior to or within the 
formation of the firm. Moreover, the value proposition can be served towards a variety of 
“customers” – suppliers, other research institutes, the funding bodies and end consumers.  
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Business model evolution in USOs is the consequences of the ongoing dynamics come from 
the interactions between and among the core components that will result in transformation in 
its cost structure and/or revenue stream. These evolutions can be initiated internally or 
externally and typically involve new resources (e.g. obtaining new research fund/grant), 
improve the competence of the USO (e.g. bringing in professional business staff to the firm), 
reengineer the organisational structure and processes (e.g. changes in the USO’s executive 
board) and/or re-defining the value propositions (e.g. providing new services or collaboration 
with other research centres). In some cases, changes in business model occur when a firm’s 
performance starts to decrease and there is hope that business model evolution may improve 
the operations processes and constitute signals about the firm’s sustainability (Bower 2003). 
However, the questions of when, how and why university spinouts business models evolve to 
reach sustainability and scalability have not been empirically investigated by previous research.   
4. Research Design and Empirical Work   
Given the nature of the research question, a multiple case study approach is adopted to uncover 
the evolution of business models through the development phases and the routs to sustainability 
and scalability. We conducted a comprehensive case study of USO_A for a period of 24 
months, supplemented by comprehensive case studies of two USOs (i.e. USO_B and USO_C) 
for 18 months, all of which have been span out from a leading university in the UK. Specifically 
for the field of healthcare and medical science, the University and local government are 
dedicating to establishing a new industrial base through spinouts and attracting inward 
investment. The selection of the case study was partly dictated by opportunities to gain quality 
access to senior management of these organisations. All three case studies specialise in health 
and medical care services that had secured substantial external funding from the National 
Health Services (NHS) and/or private equity firms. Although all three USOs were formed to 
commercialise technological innovation and provide a sustainable return to their equity 
investors, they have been formed under different frameworks used by the university 
Technology Transfer Office (TTO). The distinction between these frameworks is mainly 
related to the level of support from the TTO. We deliberately selected the case studies that 
received different level of support to analyse how different method of formation influence the 
business model evolution, and the subsequent sustainability and scalability. Finally, all of the 
cases are relatively at the sustainable return phase of development, allowing greater insights 
into the path the firms have followed over time. The descriptions of each USO are summarised 
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in Table 1. For confidentiality reasons coded-names as USO_A, USO_B and USO_C were 
employed for each of the case studies.  
 
<< Table 1 >> 
 
Staying actively engaged with the spinouts – from early 2011 to June 2013 with USO_A, and 
from January 2012 to June 2013 with USO_B and USO_C provided us with rich insights into 
the formation of the spinouts and deep understanding of the development of business strategies 
and evolution of the firm’s business model. Empirical data were gathered through several 
techniques. Firstly, 12 in-depth semi-structured face-to-face interviews were conducted with 
(a) the senior members of staff including the academic founder and/or CEOs, operations 
managers, etc. and (b) senior representatives including the Head of Venturing and Incubator 
Manager from the University TTO. The interviews carried out in at least three time frames for 
the purpose of understanding the evolution of business models within the firms and the way in 
which the key components evolved throughout the stages.    
The interview questions consisted of three parts. First, each of the founders was asked to 
describe and assess the way in which the key components of their business model were 
developed and evolved through different phases of the spinout development. Second, they were 
asked to evaluate their relationship with the university’s Technology Transfer Office and its 
impact on their business model evolution. Finally, two of senior managers of the university’s 
TTO were asked to explain the frameworks that the university is currently using to support the 
academic entrepreneur forming their spinout.  Each of the interviews last about 2-3 hours, tape-
recorded and transcripts were prepared soon after the interviews. 
The initial interviews were followed by observation of the ongoing process of the USOs’ 
development. Several follow up interviews, business meetings and telephone conversations 
were carried out to obtain updated information regarding the operational processes within the 
USO. Interviewing a number of key people involved in the development of the USOs enabled 
the researchers to cross check the interpretation of the events and extract different perspectives 
from the university, the academic entrepreneur and the firm. After conducting the case studies, 
cross-case analysis method suggested by (Miles, Huberman 1994) was employed to identify 
similar and dissimilar issues in the USOs business model evolution. Other documents such as 
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the USO’s business plans, published press articles, and rules and regulations that the firms had 
to operate within were also collected and analysed.  
5. Case Studies and Main Findings  
5.1. Case Study 1: USO_A 
USO_A was founded in 2010 by an academic entrepreneur who is a Medical Professor, in 
partnership with the University and The NHS Trust. The firm specialises in the design and 
development of Assistive Living Technologies and Services (ALTS) such as computer-based 
applications for assisted living purposes. During the first stages of development (research and 
opportunity phases), the academic entrepreneurs started to experiment the use of a simple 
platform, such as XBox EyeToy in rehabilitation. As a result of some excellent outcomes 
gained through the experiments, the AE realised the need for designing and developing a 
package consist of a game controller together with an action game to effectively improve the 
rehabilitation for both children and adults. The AE added:  
“ ... In addition to my experience, I started to learn how a business can be formed to 
commercialise these ideas (...) I realised that knowledge itself doesn't drive the market, 
money drives. So, I thought the only way that my knowledge translated is to form a 
company ...”   
The firm secured a major external resource during the pre-organisation phase. The research 
grant was awarded for the design and development of several ALTS-related products. In 
regards to the organisation composition, the USO’s executive team decided that the firm should 
act as a video game publisher. Therefore, the key value proposition of the firm was defined as 
the rehabilitation package (application and controller) designed in-house. On the one hand, 
USO_A had medical expertise with many years of experience in healthcare and medical 
studies; and on the other hand it had networks with experts in the video games industry who 
can actually devise the programme to be applicable in rehabilitation treatment.  
Initially, USO_A was not formed based on a clear organisational structure. Firstly, the decision 
of being just a publisher brought fragmentation in the organisational structure. In a standard 
structure of companies involved in video games development, there should be a middleware 
supplier who supplies the facilitating software. Thereafter, there is a game producer who has 
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the studios and the appropriate skills for designing the games. Finally, the finance should be 
provided by a publisher who is the key player with networks in the game industry. For USO_A, 
however, there were no middleware firms in this field, who were capable of providing 
facilitating software to game programmers.  
Secondly, USO_A as a university spinout has a member from NHS Trust and a member from 
the University in its executive board, both of them needed to go back to relevant committees 
at their own host institutions for approval of any decisions. That is a very tenuous and time-
consuming process which slows down decision making. In addition, the board members do not 
have the corresponding knowledge and the determination to keep up with rapid innovations in 
this constantly-changing market. Improvement of the AE’s knowledge and competency and 
the board’s decision on the structure of the firm (to act as a publisher) resulted in the evolution 
of the value proposition, hence acquisition of additional external resources throughout the re-
orientation phase. A key value proposition was added up to the initial one, which was defined 
in the opportunity framing phase. The new one was identified around the area of gathering 
medical information through the games played by the patients. The information includes the 
way the patients play the games, how often they play, whether they do what they have 
instructed by the therapist, and the weaknesses and strength of the patients in different parts of 
the game. This approach could also be used to improve the controllers and the games itself; 
hence the process of physiotherapy and rehabilitation could be improved drastically. In this 
regard the academic entrepreneur argued:  
“... We believe that this opportunity adds a great value to our rehab packages and 
assists us in improving the efficiency and effectiveness of our product ...” 
By presenting the effectiveness of the medical information in rehabilitation process, USO_A 
managed to secure several rounds of major funding in the re-orientation phase worth more than 
£2m enabling the company to start commercialising the rehabilitation packages at large scale. 
In this phase the company decided to go to the market first with a self-purchase approach 
through health products retailers. However, as the packages developed by USO_A are 
categorised as medical devices, one of the issues for the company was to gain credibility before 
going to market. It should be noted that the UK Medicines and Healthcare products Regulatory 
Agency (MHRA) is in the process of setting out regulatory conformity guidelines. So the 
company would be able to pass those regulations and register its product as an approved 
medical device. This issue is holding the company back because professional purchasing (e.g. 
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from NHS and GPs) cannot be done before they pass the regulations. Regarding this issue the 
academic entrepreneur noted:   
“... The rules and regulations are killing the start-ups in healthcare - especially when 
they have a product or service to be commercialised. Many of such companies die out 
before they even start selling anything. The last labour government set up a committee 
to investigate what made a successful SME in Medical Devices Industry, and the very 
sad conclusion was that you are only successful if you first launched in America, since 
their regulations are pro-commercialisation of medical devices not against ...”   
In the re-orientation phase when the issue regarding the organisational structure was realised, 
the academic entrepreneur decided to team up with other academics within the University to 
form two more new companies; one as the middleware provider and one as the game producer. 
The founder argued that:   
“... USO_A as a publisher stands alone, and then we have these two companies. The 
market is very new in terms of this structure, and also is very new in terms of 
distribution and how you are going to enter to the market. [USO_A], I think, is quite 
exposed but I don't think the board think the same ...” 
The academic entrepreneur believes that the new internal and external structure of the firm 
brings success to the entire chain and would assist USO_A in drawing together new resources 
in the form of specialised partners from video game industry. This change towards the 
organisation structure and novel resources is the path through the scalability loop. Table 2 
summarises the changes in the key components of USO_A’s business model throughout its 
development phases.  
 
 





5.2. Case Study 2: USO_B 
The academic founder of USO_B is a leading professor in clinical genetics and a medical 
consultant with over 20 years of experience. He and his colleagues realised that whilst 
numerous benefits of using new technologies have been noticed in the field of genomic 
research, there has been very little application in molecular diagnostics. Therefore, USO_B 
was established through a partnership between the Hospitals NHS Foundation Trust and the 
University and staffed by renowned experts from each organisation. The company started by 
focusing on developing, validating and delivering molecular diagnostics using the latest 
sequencing and genotyping technologies. By deploying these technology platforms USO_B 
has gained the capability of handling large volumes of tests ensuring its clients benefit from 
the economies of scale through competitive pricing and fast turnarounds.  
Initially in the first two phases of development, the operations were mainly research-focused 
and carried out by the academic entrepreneur and his colleagues in the University. Although 
the founding team was aware of the initial resources (that could be provided by the health 
organisations), the organisation structure including the relationship with TTO, the supply chain 
and the distribution channels was not clearly defined. Like many new start-up, USO_B 
experienced significant changes when developing the initial business model. In the opportunity 
framing phase, the model was mainly based on two equipment platforms with four staff (two 
seconded from the University and two from the Trust), and the results of the genetic testing 
were returned to the NHS Hospitals.  
The main evolvement of the business model’s key components occurred in the pre-organisation 
phase, when it was realised that the initial business model was incapable of taking the firm 
forward. The board decided to bring in professional business executives to develop a new 
business plan with a new business model. Although the key value proposition of the company 
was retained, it was re-defined as the genetic testing through advanced medical platforms that 
is the quickest testing approach and more economical. After demonstrating a strong business 
model and meeting other organisational and technological requirements, the Trust agreed to 
fund the company for £700k. However, since the budget was quite low to employ professional 
and experienced business team, the Venture Office itself got involved in running the day to day 
business within USO_B. The Head of the Venture Office reported:  
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“... I was brought in just to check the business plan, working alongside the clinicians 
from the Trust to develop the business model. After this, the university asked me to 
find a potential CEO for the company - but because the limited budget they asked me 
to do the job for a short period of time – and after nearly 5 years I’m still here. I am 
employed by the university and am a businessman rather than an academic. So half of 
my time is involved in [USO_B] operations and the other half I am helping other 
spinouts to get off the ground ...”   
The empirical evidence illustrate that USO_B is not a typical USO in a sense that it does not 
have any academic or clinical shareholders and it does not have any private investment 
company as its shareholder either. It was formed by the two institutional shareholders (i.e. the 
University and the Trust) to exploit a university IP (the initial genetic testing platforms). 
Moreover, since the pre-organisation phase, the venture was no longer managed by the 
academics, but by someone from the University Venture Office with commercial experience 
and skills. Therefore, through changes in organisation structure in pre-organisation phase, fresh 
resources were brought into the firm and the value proposition radically modified. 
In the re-orientation phase, two key revenue streams were identified. One was Research and 
Development (R&D) consultancy in which the USO gets paid for carrying out research projects 
requested by the University and/or The Trust. The second one was focusing on genetic testing 
for hereditary diseases (mainly different types of cancers).  A further income stream was later 
added to the portfolio by carrying out genetic testing for other medical labs; and also R&D 
collaboration with others was also considered as a potential income stream. According to the 
CEO:   
“...Another value stream is going to be personalised medicine - this is where you tailor 
a drug regimen to person's genetic makeup and this is we think a very lucrative 
business. This is a whole growing area in medicine and it's very new for us where we 
are in the ground floor now ...” 
 “...The main and only customer we have is the NHS - on the one hand they give us 
work to do and on the other hand they help us improving our platforms as well. We 
don't get the genetic results back to the public – we give them to the NHS and clinicians 
and they do the rest ...” 




<< Table 3 >> 
 
 
5.3. Case Study 3: USO_C 
The idea of looking at what happens with different bits of brain as well as damaged bits and 
their consequences led the academic entrepreneur to focus on drug development. After nearly 
10 years of experiments, the AE realised that there are some commercial opportunities and 
around 2001 the company was formed. During the early phases of development (i.e. research 
and opportunity framing phases), the components of the firm’s business model was not 
rigorously defined since the academic entrepreneur was focusing mainly on experiments on 
brain activities. Improvement in the AE’s knowledge on Therapeutics and his understanding 
of the commercialisation of potential products/services led to the modification of the firm’s 
organisation structure.    
The pre-organisation phase was the point when the University Enterprise Team (within the 
TTO office) was called in for more rigorous help. Through the support of the business experts 
within that team, the company secured the first investment from Northstar Equity Investors for 
the sum of £90k. The management team started to consider three main paths for the company’s 
value proposition (a) selling software to drug companies, (b) engaging with those companies 
to de-risk their drug development process using the discovered approach (consulting service 
approach), or (c) more traditional bio-tech models, by duplicating the number of drug 
candidates in the discovery process. Even though the first approach was quite successful, it did 
not convince the shareholders as the most suitable business strategy that assist the growth of 
the company. 
The company then started to focus on the consultancy approach or as some may call it FEFA 
service approach. In this approach the bigger company have several specific problems and the 
consultancy side (e.g. USO_C) is capable of addressing them. Therefore the consultancy firm 
gets paid for the solution provided to the bigger company. Regarding this approach, the 
academic entrepreneur discussed:  
“ ... We did a number of these consultancy projects, e.g. for Cambridge Laboratories. You 
could grow your business model like that - in fact lots of American companies are following 
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such an approach where they get paid to tell their scientific consultation. But still I think it puts 
a very low cap on your expectation and the growth of your company ...” 
Similar to the previous cases, a significant evolution in the firm’s business model occurred 
during the re-orientation phase when the founder realised that very few drug companies were 
running discovery programmes. As a result, USO_C decided to focus on a novel value 
proposition that was focused on what the discovery platform can actually do and what can be 
derived from them. The academic entrepreneur added:  
“… This approach helped us going beyond the more traditional, American style 
business model used in bio-tech industry. What we found was the fact that the big box 
is not in the software or the consulting service approach and we thought if we want to 
grow, we have to be part of the development process …”  
Due to the recognition of the new value proposition, the organisation of USO_C got 
restructured and new resources were brought into the firm. Firstly, USO_C entered into several 
collaboration/partnership agreements with large drug development companies. Thereafter, in 
2008, through conducting several successful projects, USO_C proved that their approach can 
be applied clinically and obtained a new investment of £50m from one of the world biggest 
hedge fund firms to significantly scale up its operations. The founder reported:  
“ ... That was a shining time for us; we had great assets like discovery platforms and 
drug candidate assets in which without money, we were not able to do anything with 
them. We became the 11th largest listed bio-tech firm in the UK, among GSK and other 
big ones ...” 
These significant and successful changes in the firm’s business model further pushed USO_C 
to expand its operations. In order to be more focused on the discovery platform, all the 
discovery functions and the scientist dealing with them moved to one of biggest centres for 
network biology in the world located in Oxford. The academic entrepreneur reported:   
“… We are now working with our partners in phase I of drugs development, examining 
whether the candidate can be survived in other phases. This will give us not £100k but 
£10m. If we can get into other phases, we are talking about much larger chunk of 
money. So, if the candidate can survive in phase 2, you will get much more than you 
could get through consulting service or selling software package…”  
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By opening the new centre, USO_C reshaped its value proposition, building on a new discovery 
team working on the unique network pharmacology platform. Regarding the near term value, 
the issue that the company management is faced is the limited number of medical assets they 
can develop. Based on the interviews, it can be noted that these barriers will gradually fade 
away once the company starts to focus more on the discovery platform as it can produce much 
more results that it has ever been developed. In this regard the academic entrepreneur noted:  
“... We have learnt that the only way really to monetise the value more quickly is to 
put our discovery platform under other people's cash mountain. One way to do that is 
to collaborate on discovery processes with larger companies in such way we get some 
share of downstream value...” 
The firm is selling partially completed development drugs to whoever is the highest bidder. So, 
the customer in this case is the largest pharmaceuticals and bio-techs who are developing drugs. 
Therefore, it can be noted that USO_C is making money based on two distinctive approaches; 
(a) selling the developed bits of drugs and (b) selling the discovery collaboration opportunities. 
In this context the academic entrepreneur clarified that:   
“... There is definitely a sweet spot in this type of business model; at one end you have 
got mainstream discovery which is still populated by molecule and at the other end, 
there are lots of people who understand what exactly we are doing and we share things 
with them ...”   
The way in which the key components of the USO_C’s business model are evolved within the 
development phases are reported in Table 4.  
 
<< Table 4>> 
 [19] 
 
6. Discussions  
The empirical data revealed that the business model evolution become considerably evident 
during the transition from the pre-organisation phase to the sustainability and scalability 
phases. These significant changes in the USO’s business model occurred as the result of one 
or a set of decisions, mainly voluntary, towards one or several core components (i.e. resource 
and competency, organisation, and value proposition). Although these decisions were 
voluntarily made, they were influenced by several internal or external factors. For instance, the 
pressures from the representatives of the university and the NHS (as the main investors of 
USO_A) forced the AE to make the decision on acting just as a game publisher, hence the value 
propositions and distribution channels had to be modified. Based on the thematic analyses of 
the three case studies we have classified the decisions into three common themes: Organisation 
structure consolidation during pre-organisation phase, innovative value composition within re-
orientation phase, and value network extension in sustainability and scalability loop. In this 
section, therefore, we will explain the ways in which the core components of the USO’s 
business model have been evolved due to the voluntary and/or involuntary decisions 
throughout the development phases.  
Research phase  
Although the USOs we studied were set up to address different objectives and each adopted a 
different organisational support structure, their founders were not clear about the key 
components of their respective firm’s business models in the first two phases of development. 
In the research phase, the academic entrepreneurs focused on understanding different aspects 
of their discipline and the way in which they can commercialise the knowledge and ideas, hence 
the business model is often not formally defined.  For instance, the academic team who 
established USO_B later started to take existing gene-testing technology from the lab and 
began their research into novel application of it across different industries. Similarly in the case 
of USO_C, the academic scientists carried out their research and experiments on brain’s 
activities through very small funds in order to test whether the results can be applied in the 
pharmaceutical industry. Therefore, this phase can be regarded as the set off for defining the 
core components of the USOs’ business model, in which improving the commercialisation 
competency of the AEs resulted in outlining the organisation structure and potential value 




Opportunity Framing Phase 
In the opportunity framing phase, the structure of the UOS’s business model remained unclear 
as the tangible or intangible assets were not yet packaged for commercialisation. It should be 
noted that none of the three academic entrepreneurs established their firms to generate wealth 
in the first place, but rather to fulfil their goals of commercialising their ideas or technologies 
developed in their research that could result in bigger impacts in the relevant industry. The path 
remained unclear in terms of how technological discoveries can be best commercialised to 
satisfy the market. In this phase, the academic entrepreneurs recognised that their experiments 
had potential commercial applications in a number of market segments, but without a clear 
vision on structuring their business model and defining their customers, suppliers, and 
distributors.  For instance, based on extensive experiments on several initial users, the academic 
team in USO_A became aware of the benefits of computer applications in rehabilitation, but 
no clear vision on the optimal routes to market.  
 
Pre-organisational Phase 
The empirical findings demonstrate that the primary change in the USO’s business model 
emerged in this phase when improvement in the AE’s competency in commercialisation and 
addressing venture credibility triggered the decisions on consolidation of the organisational 
structure. In all three case studies, the AEs realised that in order to address the concern of 
USO’s financial and operational reliability, the structure of the firms should be developed well 
through supports from the TTO. Therefore, the role of the university TTO became more 
prominent in this phase.   
Note that although the USOs have spun out from the same parent university, three different 
frameworks were used by the TTO to support their formation. These frameworks can be 
categorised as low-level (the case of USO_A), medium-level (the case of USO_C) and high-
level (the case of USO_B) support framework. We argue that these frameworks have 
enormously affected the evolution of the USO’s business models especially in the pre-
organisational phase. In USO_A, for instance, the low-level support from the University TTO 
resulted in formation of a weak executive board and therefore the firm could not appropriately 
define its position the market. Strategic decisions regarding the key components of the business 
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model changed many times during this phase; from designing and developing applications in-
house, to acting just as an app publisher and outsourcing the development processes, and from 
using General Practitioners (GPs) and hospitals as the main channel of distribution, to going to 
the self-purchase market through large retail distributors. In the case of USO_B and USO_C 
the impact of the supporting frameworks was less noticeable in the path to sustainability. The 
reason is that the spinouts either received more support in shaping their firm or tried to reduce 
the role of the University in their organisation. As an example, a professional business team 
from the TTO got involved for preparation and development of the business strategies/models 
of USO_B and in fact, after the opportunity framing phase the development of the USO handed 
to the technology transfer staff. Regarding USO_C however, the academic founder attempted 
to reduce the role of the TTO in his firm by first getting help just in the early phases of the 
development and second by obtaining assistance regarding the key components of the business 
model from private equity firms.   
Although it cannot be generalised, the empirical findings of the case studies show that a 
medium-level support from the parent university TTO has more positive influence on the path 
to sustainability and scalability. It gives more autonomy to the academic entrepreneurs to 
evolve the components of their business model while learning and improving their knowledge 
about their resources and the markets they want to serve. Whereas, applying the low-level and 
high-level support framework makes the academic entrepreneurs dependent on the university 
support even after the early phases of development. Nevertheless, changes in the USO’s 
organisation structure through maintained cooperation with the TTO resulted in securing new 
sources for the USOs; £250k for USO_A to design serious games for rehabilitation, £700k for 
USO_B to provide efficient molecular testing methods and £90k for USO_C to offer its 
discovery platforms to the drug companies. Therefore, by this phase, the business model was 
reconfigured to fulfil research contract and provide specialist consultation. 
 
Re-orientation Phase 
Securing the first major research grants during the previous phase enabled USOs to develop 
sophisticated and customer-oriented value propositions. For instance, USO_A started to focus 
on users’ information to offer more effective solutions, while USO_B developed three new 
platforms to accelerate the process of genetic testing and USO_C made two novel data 
resources available to drug development companies for more advanced drug development 
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process. These changes in the spinouts’ value propositions resulted in modifications in 
organisation structure in all three cases. For instance, USO_A brought in several academics 
from another department who had extensive experience in the game industry in order to form 
two other firms as the middleware provider and game producer. Similarly, more medical 
experts were brought into USO_B in order to improve the platforms that may enhance the time 
and quality of the genetic testing processes.    
The process of revising earlier strategic decisions (e.g. in the opportunity framing and pre-
organisational phases) occurred within all phases, however, appeared to be more notable in the 
re-orientations phases when the USOs had managed to obtain substantial resources and 
commitments.  It can be argued that particularly in the re-orientation phase, the academic 
entrepreneurs realised that the business model design must have the potential to eventually 
deliver sustainable returns at large scale. Therefore, they focused on re-defining their value 
propositions, re-structuring the organisation structure, which would result in obtaining more 
resources. For instance, these reconfigurations in USO_A were involved in revising the 
technology in order to gather users’ information to improve the process of rehabilitation. 
Within USO_B the activities were involved in modifying the platforms for accelerating the 
process of genetic testing and be more focused on personalised medicine. In USO_C the 
reconfigurations were focused on the compositions of innovative databanks that assist the firm 
entering into drug’s development processes.   
Therefore, innovative value composition impacts two core components of the USO’s business 
models. In the first place, the organisational dimension was transformed when the USOs 
realised the need for more professional staff and effective delivery channels. Second, 
illustrating customer-oriented products and services as well as venture credibility caused by 
transformed firms’ structure resulted in acquisition of novel resources and competencies i.e. 
extensive funds.   
 
Sustainable Return Phase and Scalability Loop 
All three firms studied in this research, although at different scale, have reached to a financially 
sustainable phase and, especially USO_C has started to scale up its operations. Based on the 
empirical information, a momentous incentive emerged in this phase. The USOs started to 
expand the scope of their activities or as we call it value network extension by collaborating 
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and partnership with other firms (inside and/or outside the same industry). For instance, 
USO_A realised that there are two very different customer segments; one should be targeted 
through collaboration with large health retailers store while the other groups, in addition to 
stores, have the opportunity to download games via the Internet. In the case of USO_B, after 
the initial genetic testing platforms brought a sustainable return into the firm, the company 
started to scale its operations by offering the results to other part of the NHS as their new 
customers. USO_C, similarly, has successfully progressed through the sustainability phase by 
collaborating with drug companies and providing them with the results of their discovery 
platforms. The firm therefore started to scale up its operations by engaging in drug’s 
development itself. 
Changes in USO_C’ business model enabled the firm to generate value not only from its 
existing technological platforms and become sustainable, but also respond to new commercial 
opportunities such as penetrating new market segments and collaborating with multinational 
drug companies. In the sustainability phase, USO_C initiated several collaborations with large 
pharmaceutical companies in order to become a key player in the drug development process 
rather than just act as a consulting firm. That helped the spinout to cut its operational costs 
while increase the number of projects and experiment, and further de-risk their drug 
development process. 
The decision on extending value network resulted in a drastic transformation in the USO’s 
business model because it influenced all the three core components. Essentially, it impacted 
the organisation structure of the USOs as they developed several partnerships with companies 
outside their boundaries. This either outsourced or brought in multiple activities that were 
initially performed by the USO itself or outsiders. The value proposition of the firms also 
drastically changed because they no longer focused on a single line of product or service and 
rather diversify their offers to cover new market segments. Generating value through serving a 
larger market segment and partnership with larger players in the industry resulted in a great 
transformation of the USO’s resources in which they accessed to a combination of 
infrastructure and competencies. Figure 2 summarises how different components of the USO’s 
business models changed in the last three stages of development.  
 
<< Figure 2>> 
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Table 5 presents the evolution of USOs business models through different phases of 
development, as well as internal and external determinants within each phase.   
 
<< Table 5 >> 
7. Conclusion, Contributions and Future Directions   
Previous studies of university spinouts mainly focus on their formation, but not the way in 
which they actually grow to sustainable and scalable operations. Hence, this paper attempted 
to answer to the questions of “how USOs business model evolves, and the ways in which 
interactions between and within the core components of their business model would result in 
financial sustainability and operational scalability”. To answer, we outlined a multi-phased 
development model for USOs and through employing empirical evidence gathered from 
comprehensive case studies, we demonstrated how the key components of the USO’s business 
model evolve through different phases. The empirical examination of the university spinouts 
development across several levels of analysis emphasises that, dissimilar to any other kind of 
start-ups, USOs are not clear about their business models and the complex relationships 
between its key components in the early phases of development. Hence they are incapable of 
following the traditional ladder in which the value proposition is first to defined followed by 
characterising the customer segment, classifying the key resources, activities and other key 
components of the business model.  
More specifically, in the Research and Opportunity Framing phases of development, the USOs 
do not establish a business model as such we have experienced in commercialised environment. 
Phase 1 and 2 of the evolution are purely based on the primary knowledge of the academic 
entrepreneurs in which no organisational structure and value proposition is considered by the 
entrepreneur. It is in the Pre-organisation phase of development that as a result of organisation 
structure consolidation the three key components of BM begin to shape. However, the notion 
of value proposition is still unclear due to uncertainty about the potential and available funding. 
The first commercial-type of business model (customer-oriented model) is generated in the re-
orientation phase when the direction of the three components is moving towards potential 
customer and during which professional people join the team, formal structure of supply chain 
and distribution channel is exposed and the USO has fairly clear vision about the cost structure 
and value stream. When the USOs reach an appropriate level of return, they start to extend their 
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value network and the business model is shifted towards more collaboration-oriented model, 
in which the key partners are coming to play. It is in this stage when the USOs realise the fact 
that keeping on sustainable in the industry is subject to first organisational flexibility to 
constantly revise the business model and second, collaboration with the key players in the 
industry. Soon after gaining the two above advantages, the USO would be capable of scaling 
up its operation into more production lines and serving more customers in national and 
international markets. Entering into the scalability loop indicates that the firms should come 
back to the sustainability phase when they scale up their operations, and then re-enter to the 
loop for more growth.    
This research contributes to research on the development of USOs in several ways. Firstly, it 
extends the conceptual framework proposed by Vohora et al.  (2004) by demonstrating that the 
sustainability phase should not be considered as the final stage of development since reaching 
this point does not mean that the USOs can actually scale up their operations. Hence, we 
highlighted the scalability loop, which demonstrates that after USOs become financially 
sustainable, they may start to expand their operations in order to produce more 
products/services and serve more customers. Secondly, by adding the RCOV framework 
(Demil , Lecocq 2010) to share a revolutionary perspective towards business model concept, 
this study provides a more comprehensive framework for university spinout process that takes 
into account how BM changes towards the development stages. We clarified that in addition to 
describe the configurations of business model elements (static view), the way in which a 
business model evolves (dynamic view) over time should be taken into consideration and 
examined. Hence, we explained how each stages of BM evolution are preceded throughout the 
development phases to reach operational scalability. We also contribute to the literature on 
entrepreneurship by focusing on the evolution of business model, extending previous studies 
on the role of the academic entrepreneurs or the parent university. This study also explicitly 
addresses the concerns of academic entrepreneurs seeking to commercialise scientific 
innovation and experiments through establishing a USO backed by the Parent University and 
venture capital investor. The evolution of the key components of the USO’s business model 
means that academic entrepreneur should constantly pay attention to the arrangement of their 
resources to pass through the phases and in order to generate new value propositions and to 
modify their organisation structure.   
Three types of studies are required in the future. First, future studies should investigate the 
external validity of the findings within the USOs operating in other disciplines and have span 
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out from other types of universities. Second, the effectiveness of different models employed 
by the University’s TTO in helping USOs reaching sustainability and scalability need to be 
examined.  Third, the circumstances in which business model evolution may put the USO in a 
critical stage where the founder(s) considers implementing an exit strategy require further 
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The academic entrepreneur 
and few academic 
colleagues pursue their 
interest in using 
technological innovation for 
assistive living purposes.   
Representatives from the 
Hospital and University 
joined the executive board.   
Business experts from the 
TTO recommended 
staying just as a game 
publisher. No formal 
conclusion regarding 
suppliers and distributors.  
Forming two other firms 
as the middleware and 
game producer. Initiating 
negotiations with large 
suppliers in healthcare. 
Starting collaboration 
with large health and 
medical care retailer in 





Knowledge of identifying 
the areas that computer-
based applications can 
improve the efficiency and 
effectiveness of 
rehabilitation. 
The applications that 
could be used in PC, 
laptop and other platforms 
to assist the physiotherapy.  
Rehabilitation package 
designed in-house with 
support of software and 
hardware developers. 
Medical information 
gathered through the 
package to improve the 
process of rehabilitation 
and the package itself.  
Offering more 
personalised assisted 
living technologies and 
services for self-
purchased market. 





 Research  
Phase 












Professor of Clinical 
Genetics focused on 
applying latest sequencing 
tech in molecular 
diagnostics.  
Knowledge and skills 
gained through in-depth 
experiments on genetic 
testing through new 
technological platforms. 
Securing the first major 
research fund worth 
around £700K through 
illustration of the 
efficiency of the new 
method.  
Entering into several 
collaboration with major 
labs and drug companies 
to improve the testing 
platforms.  
Although the business is 
profitable, plans have 
been prepared to improve 
and increase the level of 





entrepreneur as the main 
founder with support of 
some academic colleagues.  
Four staff, 2 seconded 
from the University and 2 
from the Trust joined the 
company to prepare the 
formal business plans.   
Bringing in another 12 
professionals to maintain 
the developed platforms 
as well as design and 
develop new platform.  
Strategic decisions to (a) 
focus more on the 
personalised medicine 
testing services, (b) get 
support from the NHS to 
improve the platforms. 
No plan has yet been 
prepared to reform the 




Knowledge of binging new 
technological innovation 
into genetic testing 
experiments. 
Innovative genetic testing 
platforms that could 
decrease the process time 
and improve the accuracy 
of the results.  
Offering a molecular 
diagnostic service using 
the latest next generation 
sequencing technology 
and services for human 
genome capture using. 
Three new platforms for 
accelerating the process of 
genetic testing and be 
more focused on 
personalised medicine. 
New testing platforms 
that can run more genetic 
tests at the same time 
with a lower 
maintenance cost.    





 Research  
Phase 












Small grants that enabled 
the academic 
entrepreneur and his 
colleagues carried out 
preliminary research on 
brains activities.  
Knowledge gained 
through the small granted 
projects.  
Securing £90k from 
Northstar Equity 
Investors. Suggestion to 
fill in IPO and become 
public.  
Joining London’s Stock 
Exchange and became 
public, which raised 
£1.3m. 
 
Raised £50m to advance 







and experiments by the 
academic entrepreneur 
and his colleagues within 
the University labs. 
No external employee – 
still the academic 
entrepreneur focusing 
on selling bio-tech 
software to drug 
companies.  
Bringing in professional 
business staff from TTO, 
engaging with drug 
companies to de-risk the 
drug development 
processes.  
Focusing more on 
partnership/collaboration 
agreement to get involved 
in drug development 
processes with big drug 
companies.  
Discovery functions and 
the scientist dealt with 
them moved to one of 
biggest centres for 
network biology in the 




The knowledge and 
experience gained through 
analysis of network system 
to identify drugs that are 
both safe and effective. 
 
Published results of the 
experiment in top medical 
journals, preliminary 
discovery platforms and 
computers.  
Clinical assets including 
several sophisticated 
discovery platforms, 
enabling USO_C to enter 
into drug development 
processes.    
The two very large data 
resources; one focuses on 
protein interacts another 
one includes 15m unique 
compounds by 2.6m 
unique proteins.  
Results of the phase I of 
drug discovery;  
examining whether the 
candidate can be 
survived in other phases.  




 Research  
Phase 












No specific resources. 
Primary knowledge of the 
academic entrepreneur in 
the field.  
 Knowledge and skills gained 
through in-depth experiments 
/ knowledge about potential 
opportunities. Still no fund.   
The first research grant to 
carry out more in-depth and 
advanced experiments.  
Several large research grants. 
– Professional and skilful 




partnership. Become public 





No Formal structure. The 
AE as the only person 
who undertook the 
initiative of 
commercialisation.  
No Formal structure. 
Negotiation with the 
University to bring 
professionals to form the 
executive board.  
Formal executive board / 
Business experts and 
professionals. No formal 
strategies regarding the 
suppliers and distributors.  
Defining the position in the 
industry - Characterising the 
distribution channel and 
supply chain management.   
Enter into collaboration 
with other USOs or private 
companies – share the risk 





product/service in this 
stage.   
Still no customer-oriented 
product/service in this stage.  
Initial results of the 
experiments.  
The intellectual property – 
the preliminary product and 
services.  
More personalised 
product/services based on 
the customers’ requirements. 
Diversity in 
products/services that can 




Internal & external 
determinants 
Academic entrepreneur’s 
lack of incentive to think 
commercially.  
Academic entrepreneur’s 
inability to research and 
articulate a clear business 
strategy.  
Formation frameworks 






and policies – 
accountability and 
transparency after IPO.  
Table 5. The Evolution of Business Models within the Development Phases in USO 
 
 
